Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / BONUS CONTENT: Dr. Jennifer Plichta, Duke University, Part 2
Transcript
- 0:00You attend the dinners and luncheons, maybe a pop up shop.
- 0:03You sign the pink car and participate in a tennis event or
- 0:07a special run or walk. So what does earlier.org do with
- 0:11all of your donations? In today's Part 1 of a special
- 0:14two-part series of Isn't That Interesting, Martha Kaley,
- 0:17Founder and Executive directorofearlier.org, speaks to
- 0:21a Duke oncologist who is putting your dollars under the
- 0:25microscope. Well, welcome back everyone.
- 0:28We have Doctor Jennifer pluck this with us again, our second
- 0:32part of the series. And so I just wanted to catch
- 0:34you up and and let her give her like a replay.
- 0:38And I had asked her to begin with this one particular slide
- 0:43that we have. So Doctor Plucko welcome and I
- 0:47look forward to asking more questions.
- 0:49OK. So if you just show us that
- 0:52slide, that would be great. Absolutely.
- 0:55Thanks for having me back. We're happy to discuss these
- 0:57topics and hopefully come into some solutions together.
- 1:00All right. So again, today we're going to
- 1:02talk about breast cancer risk and I think this is the slide
- 1:04you wanted to start on. Yes, if you don't mind, please.
- 1:08Absolutely. So this is the first project
- 1:10that I had funding from earlier.org related to both
- 1:13breast atypia and genetics, meaning the genetic changes that
- 1:17may be underlie why some people get breast cancer.
- 1:20So this particular project was looking at defining the genomic
- 1:24clonal relationship, meaning how are these things connected
- 1:27between these atypical breast lesions and invasive breast
- 1:30cancer. And as you can see here, there's
- 1:33a progression that happens in the breast.
- 1:34Not in all patients, they're not in all women, but in some on the
- 1:38left, we have a normal milk duct.
- 1:40So if you think of the breast as, you know, making breast
- 1:42milk, and then how does that breast milk get out?
- 1:44It goes through these milk ducts, which are like pipes.
- 1:46They just carry milk. And so if you cut that pipe on
- 1:49end, that's what we see on the far left.
- 1:51But as we get older, there's lots of changes that happen in
- 1:54the body, including in the breast.
- 1:56And one of the first things we see is what we call hyperplasia,
- 1:58meaning that layering of cells start to increase.
- 2:02The next thing we see though, is sometimes those cells start to
- 2:04look a little funny or atypical or abnormal, and that's what you
- 2:08see here in the middle picture. And then for an even smaller
- 2:11subset of women, you'll get even more changes that happen in the
- 2:14breast. And that's how that we get the
- 2:15development of ductal carcinoma and site 2 or even invasive
- 2:18breast cancer. And I had asked earlier and I
- 2:23wanted to just have you answered this question for me about how
- 2:27does the cell decide it's going to be atypical or how do we come
- 2:31up with that or what can we do with that?
- 2:35Yeah, and it's a great question, and I wish we had the answers
- 2:37for that. We'd be a lot further along if
- 2:39we did, but unfortunately we don't.
- 2:41I really understand why some women get atypia and some women
- 2:44don't. It could be genetic related,
- 2:46meaning there are things that people are born with that are
- 2:48putting them at risk for developing these atypical cells.
- 2:52Kind of like we know that some people are born with germline
- 2:54genetic mutations like BR in BRCA 1 and BRCA 2 that
- 2:58predispose them to getting breast cancer.
- 3:00Maybe there's something similar that makes them more likely to
- 3:03get these atypia. We're not quite sure.
- 3:05It also could be environmental, meaning again, maybe there's
- 3:08something we're exposed to in our environment, some kind of
- 3:11toxic exposure. Maybe it's something even a
- 3:13little bit seemingly more innocuous, like the hormonal
- 3:16exposure of the breast. So perhaps, you know, having
- 3:19more hormonal exposure to that breast tissue is making these
- 3:22cells start to turn in a way that predisposes somebody to
- 3:25subsequently getting breast cancer.
- 3:27Most likely it's some combination of those things and
- 3:30that's why we haven't figured it out yet because it's super
- 3:32complicated. But I think that, you know,
- 3:33perhaps some of the work we're doing and today is gonna help
- 3:36lead to some of those answers. So the first question you might
- 3:38ask yourself is why do people get breast cancer?
- 3:41Well, we know that some people who get breast cancer before
- 3:43that, they have these atypia. They have these atypical
- 3:46lesions. So now we say, well, maybe they
- 3:48got cancer because they had atypia.
- 3:50But then the next question is you so eloquently poses, well,
- 3:53why did they get atypia? So we're just kind of slowly
- 3:55working our way backwards. But potentially the things we
- 3:58find from this study could help continue that conversation about
- 4:01trying to backtrack. Well, how did we get here?
- 4:03Well, if now we're here, then how did we get there?
- 4:05So just again, kind of a sequential way to work through
- 4:08these questions. Well, thank you for humoring me
- 4:11to answer that because I had no, I was very puzzled about that
- 4:15and I look forward to more research going on for that.
- 4:18So if you want to just go ahead then with your slide
- 4:22presentation, that's great. Happy to do so.
- 4:26All right, so again, just a quick refresher of the anatomy.
- 4:28Again, breast tissue, one of the things that it can do is make
- 4:32breast milk. And so breast tissue, although
- 4:34it's mostly fatty, it does have these lobules that make milk.
- 4:37And again, remember we just talked about those milk ducts
- 4:39that carry breast milk. So that's what we're talking
- 4:41about here. Those milk ducts is the process
- 4:43where some of this is happening. So again, if we take that milk
- 4:45duct, cut it on end, this is kind of what it looks like on
- 4:48the left. And as probably most women get
- 4:50older, you start getting some of these changes, whether it be the
- 4:53hyperplasia, maybe even a little bit of atypia.
- 4:55And again, in a few subset of women, they'll go on to get
- 4:58those breast cancers that we talked about.
- 5:01And so this is really the relationship we're gonna be
- 5:02looking at today is between atypia and those who eventually
- 5:06get breast cancer. Are those two things connected
- 5:09and are they specifically genetically related?
- 5:12So this study was looking at that relationship between the
- 5:15genetic changes that we see invasive breast cancer and this
- 5:19particular one was looking at DCIS.
- 5:21So kind of that's in between step.
- 5:23And we did find in this particular study, which was done
- 5:26a couple years ago, that there does seem to be about an 80%
- 5:29relationship of invasive cancer related to a prior DCIS
- 5:33diagnosis that was in the same breast.
- 5:35And this is really what made me think, well, if the DCIS and
- 5:38invasive breast cancer are related, why wouldn't the atypia
- 5:41and invasive breast cancer be related?
- 5:43Because as I showed you on the last diagram, that's kind of the
- 5:46step right before that. And so that's really where this
- 5:48study picks up. So again, are these atypias,
- 5:51these atypical lesions genetically related to the
- 5:54breast cancer that people would sometimes get down the road?
- 5:57So to answer this question, we looked at our Duke material and
- 6:00identified a series of cases or patients who had a TIPIA that
- 6:03eventually went on to get invasive breast cancer in the
- 6:05same breast. We had a pathologist that
- 6:08identified those areas in the specimens and did some
- 6:10dissection and some DNA extraction of those samples.
- 6:15And then we performed whole genome sequencing to provide
- 6:18information on copy number variations along the genome.
- 6:20So again, trying to do some genetic analysis to look at the
- 6:23similarities and potentially differences between the atypia
- 6:26they had and the cancer that they developed a few years
- 6:29later. We were eventually able to
- 6:31identify 12 cases who had sufficient tissue in both the
- 6:34atypia specimen and the invasive cancer specifications.
- 6:37The average age of patients was a little shy of 60 years old.
- 6:41The average interval or time between their atypial diagnosis
- 6:44and their breast cancer diagnosis was about five years
- 6:47or 63 months. And invasive cancers arose or
- 6:51developed in the same or nearby region in 10 or nine of those 12
- 6:55cases. And ten of those cancers were
- 6:57hormone sensitive or ER positive.
- 6:59Only one of them was triple negative.
- 7:02And there was no marker biomarker data like ERPR and HER
- 7:052 available on the last case. Oops, sorry, going too fast.
- 7:10So to assess the similarity or dissimilarity, we looked at a
- 7:14final concordance score, which measures the similarity between
- 7:17the two samples between the atypia and the cancer.
- 7:20And the score ranged from zero, meaning they were totally
- 7:23unrelated, to 1, meaning there was perfect relatedness between
- 7:26the atypia and the invasive cancer.
- 7:28So when we look at these scores, that's what we're looking for.
- 7:31We, if there's a zero, probably not related.
- 7:33If there's a one, they're definitely related.
- 7:35So this is the, these are samples from one particular
- 7:38patient who is 58 years old and there was about a one year
- 7:42interval between the diagnosis of a Tipia and the invasive
- 7:45cancer. And you can see here in the pink
- 7:48font down here that the related score was 0.798.
- 7:52Remember if we get all the way to 1, there's definite
- 7:54relatedness. The closer to 0, no relatedness.
- 7:57So for this particular patient, we can see that there was a fair
- 8:00bit of relatedness between the atypia and the invasive cancer.
- 8:03So mostly those were diploid, but there were a few copper
- 8:06number variants that were shared and those were indeed highly
- 8:09related. So again, just to kind of show
- 8:11you picture representation of the data that we're looking at.
- 8:14But the take home point is that again for this particular
- 8:16patient, there seemed to be a lot of relatedness between their
- 8:19atypia and their invasive cancer when it comes to the genetic
- 8:22changes we saw in both of those specimens.
- 8:25So this is just to give you another patient here who was 62
- 8:29years old and this had a much longer time gap, so almost 10
- 8:32years between their atypia and their invasive breast cancer.
- 8:36And if you compare the invasive breast cancer on the left to the
- 8:39middle picture, which is the atypia, the relatedness was not
- 8:42so good. So remember, 0 is no
- 8:43relatedness, 1 is perfect, and this is closer to 0 than to one
- 8:47at 0.39. Interestingly, this patient had
- 8:51another area of hyperplasia, which is remember that's just
- 8:53where those cells have started to expand.
- 8:55They don't look funny yet or atypical, but they've just
- 8:57started to expand in the milked up.
- 9:00And there was actually more relatedness between that
- 9:02hyperplasia to the invasive cancer than there was from the
- 9:05atypia to the invasive breast cancer, which is interesting
- 9:08because histologically it looks more like the atypia should go
- 9:11to the invasive cancer. But in this case, maybe the
- 9:14hyperplasia kind of skipped over that step and was maybe more
- 9:17closely related to the invasive breast cancer.
- 9:20So just kind of an interesting finding for this patient that
- 9:23this ADH and hyperplasia were definitely related and the
- 9:26hyperplasia was more related to the invasive breast cancer than
- 9:29the atypia area. So the conclusion so far from
- 9:32this study is that shared copy number changes in atypia and
- 9:35invasive cancer suggests that most of these are genetically
- 9:38related, which is similar to what we found in DCIS.
- 9:41The degree of similarity did not correspond closely to the timing
- 9:45of events or the location of the breast.
- 9:47And these data, though, are still being analyzed to
- 9:49determine more precise boundaries.
- 9:51And this will help guide whether these lesions are indeed
- 9:53clonally related. To our knowledge, this is some
- 9:55of the first data that's been generated looking at atypia and
- 9:58subsequent invasive breast cancers, specifically looking at
- 10:01clonal relatedness. Any other questions about
- 10:04project #1? No, that's great.
- 10:06Thank you. I appreciate that.
- 10:09Of course. Shall we go on to project #2?
- 10:11Yes, please. That would be great.
- 10:13Excellent. So I was very fortunate and was
- 10:16given the opportunity to work on another project that was totally
- 10:20unrelated actually to the first one.
- 10:22And this one is more of a qualitative study because what
- 10:25we were looking at is trying to understand for patients who have
- 10:29genetic mutations related to breast cancer such as BRCA and
- 10:32BRCA one and two or other genes, why they may or may not share
- 10:37that information with their family.
- 10:38Because obviously, if a patient has that genetic mutation, it's
- 10:41very likely and possible that other family members have that
- 10:45same genetic mutation and thus same risk of developing cancer,
- 10:48breast cancer, and sometimes other cancers.
- 10:50And so this could be really important information to share
- 10:53with our relatives so that they can understand what their risk
- 10:56is and maybe what screening tests they should be doing, how
- 10:59often to do that. And perhaps some people might
- 11:02choose to undergo prophylactic surgeries to help reduce that
- 11:04risk of cancer, again, breast cancer or otherwise.
- 11:07And so we really wanted to better understand why more
- 11:10patients aren't sharing this information with their families.
- 11:13So to answer this question, we conducted two different
- 11:16qualitative studies. 1 was surveys, which have been
- 11:19completed and the other is actually interviews.
- 11:21And our last interview was just done just like a week ago.
- 11:24I don't have that complete data set yet.
- 11:27We've completed the analysis for half of them for 9:00.
- 11:29But again, we just finished our last interview.
- 11:31So now we need to analyze the other half.
- 11:33So hopefully that data will be forthcoming.
- 11:35But those are kind of the two ways that we were trying to help
- 11:37better understand this process. So again, for the surveys,
- 11:41because that's where I have a complete data set and analysis,
- 11:44we had 162 respondents, but there were eight of them who did
- 11:48not answer all the questions. So ultimately our final, our
- 11:52final data set was from 154 patients.
- 11:54Looking at what those participants look like, you can
- 11:57see the median age was about 47 years old.
- 12:02We did have predominantly white patients that were responding at
- 12:04about 80%, but we did have 8% that identified as Black or
- 12:08African American and a few more percent that were Asian and
- 12:11otherwise. We did have about 5% also that
- 12:14identified as Hispanic, Latino or Spanish, mostly women that
- 12:17answered these surveys, so about 78%.
- 12:21And you can see gender identities listed there, mostly
- 12:23cisgender. Marital status is also provided
- 12:26and you can see that annual household income was a little
- 12:29bit high. So perhaps suggesting that this
- 12:31is a higher socio demographic population.
- 12:36Similarly you can see similar changes in the OR similar
- 12:39distribution of highest level of education that this cohort of
- 12:42people who responded did tend to be highly educated.
- 12:44In fact 12% had a doctoral professional degree.
- 12:47So definitely a highly educated cohort that responded to our
- 12:50survey. In terms of what types of
- 12:52mutations they had, you can see that the mutation group, many of
- 12:56them or half of them had the mutation in BRCA one or BRCA 2.
- 13:00But we also had about a third of them that had mutated in other
- 13:03moderate penetrance genes such as like check 2 ATM.
- 13:07Those types of things, of those who responded, many of them had
- 13:10at least one or two children. In fact, over half of our
- 13:12respondents had at least one child and how many of and
- 13:16similarly, about 80% had at least one biological sibling.
- 13:19So again, these are people who they might share this genetic
- 13:22information with. So trying to get a sense of, you
- 13:25know, who would be available to share information with because
- 13:27maybe you didn't share it because you don't have any
- 13:29children and you don't have any siblings, which isn't super
- 13:31helpful. But if you do have children and
- 13:33siblings, again, why are you are you not sharing that
- 13:36information? So some of the survey responses
- 13:38here, since receiving genetic test results, have you shared
- 13:41that information with your blood relatives?
- 13:43In terms of children, you can see that many people had shared
- 13:47it with their biologic children, but you can see almost 8% had
- 13:50not shared it with their children yet.
- 13:52For those who had siblings, again, about little under 5% had
- 13:55not shared it with their siblings and another 6% or so
- 14:00had only shared it with some of them.
- 14:01So again, about 10 of them, 10% had not shared it with their
- 14:04children. About 10% had not shared it with
- 14:07siblings, at least not all of them.
- 14:09In terms of parents, there was a high degree of sharing there at
- 14:12about 60%, but again, another 10 to 15% had not shared it with
- 14:16both of their parents. In terms of other biological
- 14:19relatives, you can see a lot of sharing there going about 65%,
- 14:23but actually about 1/3 had not shared it with any other
- 14:26biological relatives, which is super important because it's not
- 14:30just the parents and the children that can have these
- 14:32similar genetic changes. It's also the aunts, the
- 14:34grandparents, the cousins that might have similar changes.
- 14:37So it is really important that these changes are shared with
- 14:40more family members other than maybe our first or second degree
- 14:43relatives. Some additional questions that
- 14:45we ask people. How confident are you that you
- 14:46could get advice or information about health or medical topics?
- 14:49So our again, our population was very educated and higher socio
- 14:54demographic class. So they seem to be very
- 14:56confident that they're good at getting information about their
- 14:58health. How would they describe their
- 15:00knowledge of cancer genetics? So not as not as familiar with
- 15:03genetics. We can see only 43% said
- 15:06slightly and another, you know, 25% or so said not knowledgeable
- 15:09at all on that particular topic. Cancer genetics after meeting
- 15:12with the genetic counselor though provided a lot of great
- 15:15information when they met with our genetic counselors.
- 15:17And so then many of them became or felt that they were very
- 15:20knowledgeable on the topic. In fact, if you add up the very
- 15:23and extremely over half felt that they had that level of
- 15:26knowledge after meeting with the genetic counselor, how confident
- 15:29were they in their ability to understand their results?
- 15:32Again, people were pretty confident very or fairly
- 15:35confident about 80%. How confident in your ability to
- 15:38explain those results? Because again, you might
- 15:40understand them for yourself, but can you explain them to your
- 15:42family? But again, you can see here that
- 15:45about 90% felt very or fairly confident that they would be
- 15:48able to explain those results to others.
- 15:50And then how confident are you in your ability to understand
- 15:52the impact on other family members?
- 15:54So do you understand that because you have this, it's
- 15:57something that could affect other family members?
- 16:00And again, we see that about 90% said, yeah, I'm pretty confident
- 16:04that I understand how this would impact others.
- 16:06So if I understand how it impacts them, why might I not
- 16:09share that information? So it's kind of trying to
- 16:11understand our cohort a little better.
- 16:14So how much do you think genetics that's passed on from
- 16:16one to another determines whether or not a person will
- 16:19develop cancer? So again, showing good
- 16:20understanding about 95%. So that it probably has a big
- 16:24impact. How important is it to know that
- 16:26information? Again, 65% said it was very
- 16:29important or a lot of it a lot important.
- 16:32How important is it to knowing genetic information for
- 16:35detecting cancer early? So knowing what kind of
- 16:37screening test to get. Again, 85% said a lot.
- 16:41So they, they think they can explain it to others, they know
- 16:44that it's important, they know that it can help detect cancer
- 16:46early or prevent it altogether. So again, our very in tune
- 16:50respondents here. So how important were the
- 16:52following for sharing? How important was it to give
- 16:55this to your blood relatives about their genetic risk?
- 16:58So many patients felt that it was extremely important.
- 17:01But you'll see here that, you know, another 2% and 3% said it
- 17:04really wasn't important at all or it was only slightly
- 17:07important. So 5% kind of thought that how
- 17:09important is it to encourage your relatives to undergo
- 17:12genetic testing? Again, many patients said that
- 17:14it was extremely or very important.
- 17:16But interestingly, again, about 6 or 7% said it was only
- 17:19slightly important or not important at all, which is a
- 17:22little disappointing to see. The doctor or genetic counselor
- 17:25encouraged me to share the information.
- 17:27So, you know, how important was that that I recommended it for
- 17:30them? Did that help them decide?
- 17:32And you can see here, didn't really matter what that was
- 17:34recommended by the doctor of the genetic counselor because again,
- 17:3715% that those opinions or suggestions didn't really help
- 17:40or didn't really influence their decision to share or not share.
- 17:44How about South, your relatives could make family planning
- 17:46decisions. Would that entice, you know,
- 17:48entice you to share this information more?
- 17:50Again, that wasn't particularly important for many people.
- 17:53About 2025% said that really didn't make a difference.
- 17:56How about to share the information you learned because
- 17:58you thought it was interesting. You're like, hey, I learned this
- 18:00cool thing, you know, is that something?
- 18:02Is that a reason why you might share?
- 18:04And that again, wasn't particularly important to
- 18:06people. About 25%, really not important.
- 18:08So much sharing your feelings about your genetic test results,
- 18:12again, not particularly important.
- 18:13One thing we thought is, well, maybe they wouldn't do it for
- 18:15themselves, but maybe if they understood that it helped
- 18:18others. So if you knew it could help
- 18:19them with, was that a reason for sharing?
- 18:22And interestingly, that really wasn't a reason at all.
- 18:24In fact, about half of people said that really didn't play
- 18:27into their decision making process about why they did or
- 18:29did not share information. So a few more questions here
- 18:33that we ask people again, maybe why you didn't want to share
- 18:37this information. Why did you know, why might you
- 18:39not share it? You know, one person, some
- 18:41people felt that they didn't want to worry or upset them.
- 18:43But again, for most people, that wasn't particularly impertinent.
- 18:46But there were about 5 to, you know, 15% that said that was
- 18:50important is they didn't want people to be worried.
- 18:52You know, if you're not close to those relatives, maybe that's
- 18:54why you didn't share. And again, about, you know,
- 18:562530% said that was a reason why they didn't share the
- 18:59information. Maybe you don't have their
- 19:01contact information. So again, that was about 15% or
- 19:05so they didn't share because they didn't have contact info.
- 19:07Hard to share it with with them if you don't have their phone
- 19:09number or e-mail. Privacy concerns were not a huge
- 19:12concern, but they were for some patients, you know, for about
- 19:15another, again, 10 or 15%, maybe you didn't understand how to
- 19:18explain it. So as we saw before, many of
- 19:21them felt very comfortable with this information and thought
- 19:23they could explain it. So this didn't really seem to
- 19:25play out as a reason. I don't think this information
- 19:28is useful for my relatives. So interestingly, yeah, about
- 19:3110% thought they didn't think it would be super useful for them.
- 19:35And then last but not least, some people were having trouble
- 19:37themselves. And so maybe it was difficult
- 19:39for them to relay to others because they themselves had not
- 19:42really fully kind of internalized what that meant and
- 19:44how they were going to deal with that.
- 19:45Some additional questions that we have moving forward with
- 19:48regards to genetic counseling. What are the first steps that
- 19:50someone should take and who, in your opinion, should seek
- 19:53genetic counseling? So I really feel like when
- 19:56somebody wants to have genetic counseling, it really should be
- 19:59open to anyone. And that's really the model that
- 20:01we have here at Duke. However, it's not the model that
- 20:03we see everywhere. So sometimes seeing a genetic
- 20:06counselor can be a very precious commodity because there are not
- 20:10enough genetic counselors in this country.
- 20:12So sometimes that person providing genetic counseling is
- 20:14our primary care doctor. So I think that is a good place
- 20:17to start for anybody. So if there's anybody out there
- 20:20who's interested in genetic testing, a great place to start
- 20:23is with your primary care, because some of them will order
- 20:25that testing themselves and then other.
- 20:27Other ones will refer you over to see a genetic counselor.
- 20:29So that kind of is the last question.
- 20:31I think that goes with project #2.
- 20:34Shall we go on with these questions or did you have any
- 20:36other questions about project #2?
- 20:38My one question I had about Project 2 was I was looking at
- 20:41the age group that was the focus and I wondered about the
- 20:48openness for people to talk about breast cancer in the 1st
- 20:52place. I know when I was first
- 20:56diagnosed it, nobody really talked about it or was really
- 21:00kind of afraid to talk about it. And I was speaking with another
- 21:03survivor and she said, you know, that was exactly what happened.
- 21:06She said that she didn't even when she learned she just, she
- 21:11didn't want to share it with her children.
- 21:14She didn't want to share it with anybody.
- 21:15But then she finally decided, oh, yeah, OK, well, maybe I just
- 21:19better do that. And she is a physician.
- 21:22So, you know, it was back in the day we didn't feel flexible
- 21:28enough or comfortable enough to to talk about breast cancer.
- 21:33Yep. And I, I think your point is
- 21:36well taken and I think that, you know, some of that has changed
- 21:38over the generations, but I absolutely see that all the time
- 21:41every week in clinic. I always have some patients,
- 21:44whether it be generational or cultural even.
- 21:47Sometimes it's just not a cultural norm to share that kind
- 21:49of information. And I think genetics is the same
- 21:52way, right? So sometimes it's acceptable to
- 21:54share a diagnosis like cancer. Sometimes it's acceptable to
- 21:57share genetic things like that. And other times it's not.
- 22:00It's just not appropriate in that situation or in that
- 22:03relationship or in that culture, whatever that situation may be.
- 22:07And I think there are definitely some nuances there that we've
- 22:09not fully understood. And that's really where I think
- 22:12these interviews that we're doing.
- 22:13So I shared the survey data with you, but these interviews we
- 22:16were doing, I think we're going to dive a little deeper into
- 22:18some of those topics and hopefully give us a better
- 22:21understanding of how we might be able to work around that.
- 22:24You know, is it maybe there's some way that we can share
- 22:27things more anonymously so that it doesn't identify things back
- 22:30to a person? You know, I'm not quite sure
- 22:32what the answer is, but I think that, you know, if we get a
- 22:35better understanding of why people aren't sharing that
- 22:37information, then we can start developing solutions about how
- 22:40to work within that context. Expecting the rights of that
- 22:43person to maybe not want to share all of the details of
- 22:46what's going on with them, whether that be their cancer,
- 22:48their genetic information, still getting their family members the
- 22:51information that they need so that they can make the decisions
- 22:54that are best for them. Well, thank you.
- 22:56I I appreciate that. And I think that maybe this
- 22:59maybe for those who watch this or listen to this, that might
- 23:04give them some fortitude to go ahead and and look, look into it
- 23:10for them. So, so OK, now you can roll on
- 23:13with the last of the questions. That would be great.
- 23:17Yeah. So there were just a few more
- 23:18questions that the team had posed to me, so I just thought
- 23:20we could take a minute to go through some of those.
- 23:23So how have the grants supported and influenced my research
- 23:25journey? I really feel like this has been
- 23:27critical to kind of continuing to move some of this research
- 23:30forward. Genetics in particular is
- 23:32something that I'm very passionate about, as is kind of
- 23:36the high risk population. So why do people get breast
- 23:38cancer? Who's getting breast cancer?
- 23:40I think if we can really identify some of those risk
- 23:43factors, then maybe we can either prevent those risk
- 23:46factors like the atypia or if we understand, you know, who has
- 23:50these genetic mutations. You know, once we've identified
- 23:53somebody, we don't have to look very far.
- 23:55We can just start testing their families.
- 23:57So it's really important that the families get tested so that
- 23:59we can again find these high risk populations in theory could
- 24:04be pretty easy to find. Cuz I know if this persons got
- 24:06it, that some people in their family have got it.
- 24:08So I'm really hoping that this is gonna continue to move these
- 24:12fields forward and try and again identify these people who have
- 24:15an increased risk of developing breast cancer so that hopefully
- 24:19we can either learn from that process and prevent that process
- 24:22from happening or potentially help them get better screening
- 24:25or even do undergo some preventative strategies.
- 24:28So this has really helped me continue in this space, both
- 24:31clinically and from a research perspective, and hopefully will
- 24:34be the foundation for many years of research to come.
- 24:38So in five years, where do I see the earlier detection of breast
- 24:41cancer? Again, I think if we can really
- 24:44hone in on some of these higher risk populations, that's really
- 24:48going to help us figure out how to screen these populations and
- 24:51how to prevent it in these specific cohorts.
- 24:54You know, ideally I'd like to prevent breast cancer in
- 24:56everyone, but probably the best place to start is in people that
- 24:59we know are more likely to get it because we know if we wait
- 25:02long enough, a lot of these people are going to get breast
- 25:04cancer. So I think that's a very rich
- 25:06population to focus on. And then what we learn from that
- 25:09population, we could then maybe extrapolate to the more general
- 25:12population. But I think by starting in a
- 25:14group where we know many of those patients are going to
- 25:16eventually get breast cancer, if we can prevent it in them or
- 25:20screen them in a in a better way so that we can find it as early
- 25:23as possible, that's going to be the ideal place to start.
- 25:27And then the last thing you had asked me about is this really
- 25:29cool study that Duke is a part of, which is actually using a
- 25:33patient or woman's breath to detect breast cancer.
- 25:38This is a very novel study and approach that we are now looking
- 25:43at. It is not actually a study that
- 25:45is being conducted that was started at Duke.
- 25:48Duke is a participating site, but we are excited to be
- 25:52actually, I think one of the first sites.
- 25:53I think we're number the site #2 to open in the United States.
- 25:56So we're very excited to be a part of this work and to support
- 25:59this study because I think it would be a really cool thing to
- 26:01do if we could detect breast cancer by simply breathing into
- 26:04this device. And it would tell us, you know,
- 26:06whether or not there's likely to be cancer in that patient at
- 26:08that very given time. Cohort that we're currently
- 26:11starting with is women with dense breast tissue, because we
- 26:15know that for those women in particular, screening mammograms
- 26:18are probably not as good. And so there's question of do we
- 26:21need to do ultrasound? Do we need to do MRI?
- 26:24You know, what is the best way to look at these women who have
- 26:27dense breast tissue? So this particular study is
- 26:30saying if those people who have dense breasts have abnormal
- 26:33findings, you know, could we add this breath test to their a work
- 26:37up and help determine whether or not, you know, they're likely to
- 26:40have cancer. So hopefully it would help
- 26:42improve the, you know, accuracy of the screening process.
- 26:46So not only you get a mammogram, but you get a mammogram and you
- 26:49give a breath and you know, between the two those two
- 26:51things, we might be able to determine whether or not that
- 26:53person's likely to have breast cancer at that very moment.
- 26:56So it's a really cool study. We're super excited to have it,
- 26:59have it open. We actually just enrolled our
- 27:01last patient, our first patient. I mean, I think last week it was
- 27:05the weeks are flying by, but and hopefully we're going now that
- 27:08we've got the first one on study, we're going to keep
- 27:10bringing people in. So if you got dense breast
- 27:12tissue and you're getting mammograms at Duke, you might
- 27:15just be approached by somebody from our study team.
- 27:17That is fantastic. I just, I find that so
- 27:20interesting, particularly since my chocolate lab helped me find
- 27:24my breast cancer so. Something to it.
- 27:27Yeah. So I just think it's a really
- 27:29important study to to begin studying a lot in depth.
- 27:35Well, I have to say I I could talk to you all afternoon
- 27:38because I think it is so interesting and you're such a
- 27:42good instructor and so clear. So I really, really appreciate
- 27:46this. And as you gain more
- 27:49information, I would love for us to update that too.
- 27:53That sounds great, I would love that as well.
- 27:54It's been great chatting with you.
- 27:56So happy we could share our work with you and thank you for the
- 27:58support. Thank you.
- 28:00Have a great day. Thank you, Jennifer.
- 28:02You too. This episode of Isn't That
- 28:05Interesting was made possible thanks to volunteers and donors
- 28:08just like you. It was hosted by Martha Kaley,
- 28:11founderofearlier.org and edited by Liam Mcburney.
- 28:16I'm Valerie Amsterdam, reminding you that for the last 30 years,
- 28:20this North Carolina based organization has helped fund
- 28:23groundbreaking research all over the world, from molecular
- 28:27imaging to a sensitive blood test for breast cancer.
- 28:30Plain and simple, earlier detection saves lives.
- 28:33And you can help host a fundraising event, make a
- 28:36donation, or volunteer your time.
- 28:38You can find us not only on the web, but on Facebook and
- 28:41Instagram too. Let's change the picture of
- 28:44breast cancer together.